Generic Name:
Niacin/lovastatin
Project Status:
Complete
Therapeutic Area:
Hypercholesterolemia and mixed dyslipidemia
Manufacturer:
Oryx Pharmaceuticals Inc.
Brand Name:
Advicor
Project Line:
Reimbursement Review
Project Number:
SR0042-000
Details
Submission Type:
Initial
Indications:
Hypercholesterolemia and mixed dyslipidemia
Recommendation Type:
List
Final Recommendation:
Recommendation:
(tentative)